+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

NGS Library Preparation Market By Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics, Discovery), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) - Global Forecast to 2030

  • PDF Icon

    Report

  • 227 Pages
  • September 2023
  • Region: Global
  • Meticulous Market Research Pvt. Ltd.
  • ID: 5734581
UP TO OFF until Jan 10th 2025
The global NGS library preparation market is projected to reach $3.62 billion by 2030, at a CAGR of 14.8% from 2023 to 2030.

Following a comprehensive primary and secondary study and an in-depth analysis of the market scenario, this report provides the key drivers, constraints, challenges, and opportunities of the industry. This market is driven by the declining costs of sequencing, the increasing prevalence of cancer and genetic disorders, the growing utilization of NGS in disease diagnostics and precision medicine, and rising R&D investments and healthcare expenditures.

Furthermore, increasing applications of next-generation sequencing technology and collaborations between vendors to develop automated library preparation protocols provide a significant growth opportunity for this market. However, the availability of alternative technologies and the low chances of identifying positive actionable mutations for precision medicine may restrain the growth of this market. Additionally, the regulatory and standardization concerns in diagnostic testing and the limited expertise and sequencing capabilities of small & mid-sized laboratories pose a major challenge for the players operating in this market.

Based on product, in 2023, the reagents & consumables segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the increased demand for reagents & consumables for NGS library preparation due to the high penetration of NGS technologies in disease diagnostics and genomic research.

Based on application, in 2023, the disease diagnostics segment is expected to account for the largest share of the NGS library preparation market. The increased utilization of NGS technologies, especially in precision medicine and companion diagnostics, and growing adoption in infectious disease diagnostics is expected to boost the growth of this segment.

Based on sequencing type, in 2023, the targeted sequencing segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the increased adoption of this sequencing type due to its advantages, such as cost-effectiveness and rapid sequencing for identifying specific gene-associated diseases.

Based on end user, in 2023, the hospitals & diagnostic laboratories segment is expected to account for the largest share of the NGS library preparation market. The large market share of this segment is attributed to the increased hospitalization rates, especially in developing economies, increased penetration of NGS technologies in hospitals & diagnostic laboratories, and the high prevalence of various infectious & chronic diseases requiring complex genomic sequencing.

An in-depth analysis of the geographical scenario of the global NGS library preparation market provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America) along with the coverage of major countries in each region.

In 2023, North America is expected to account for the largest share of the global NGS library preparation market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Asia-Pacific is expected to be the fastest-growing region of the global NGS library preparation market.

The key players operating in the global NGS library preparation market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (U.S.), Tecan Group Ltd. (Switzerland), Merck KGaA (Germany), and Diagenode S.A. (Belgium) (Subsidiary of Hologic, Inc. (U.S.)).

Scope of the Report:

NGS Library Preparation Market, by Product

  • Reagents & Consumables
  • Library Preparation Kits
  • DNA Library Preparation Kits
  • RNA Library Preparation Kits
  • Other Reagents & Consumables
  • Instruments & Workstations

Note: Other reagents & consumables include various extraction kits, amplification kits, consumables, and laboratory reagents


NGS Library Preparation Market, by Application

  • Disease Diagnostics
  • Cancer Diagnostics
  • Reproductive Health Diagnostics
  • Infectious Disease Diagnostics
  • Other Disease Diagnostic Applications
  • Drug Discovery
  • Other Applications
Note: Other disease diagnostic applications include applications in cardiovascular diseases, detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and foodborne illnesses.

Note: Other applications include basic research (genomics, molecular biology, and other life sciences), agriculture & animal research, and forensics & food microbiology.

NGS Library Preparation Market, by Sequencing Type

  • Targeted Genome Sequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Other Sequencing Types

Note: Other sequencing types include degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing


NGS Library Preparation Market, by End User

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Academic Institutes & Research Centres
  • Others End Users

Note: Other end users include forensic laboratories & security agencies, the food industry, and the agriculture industry


NGS Library Preparation Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1 Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2 Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.4. Assumptions for the Study
2.5. Limitations for the Study

3 Executive Summary

4 Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Declining Costs of Sequencing
4.2.2. Increasing Prevalence of Cancer and Genetic Disorders
4.2.3. Growing Utilization of NGS in Disease Diagnostics and Precision Medicine
4.2.4. Rising R&D Investments and Healthcare Expenditures
4.3. Restraints
4.3.1. Availability of Alternative Technologies
4.3.2. Low Chances of Identifying Positive Actionable Mutations for Precision Medicine
4.4. Opportunities
4.4.1. Increasing Applications of Next-generation Sequencing Technology
4.4.2. Collaborations Between Vendors to Develop Automated Library Preparation Protocols
4.5. Challenges
4.5.1. Regulatory and Standardization Concerns in Diagnostic Testing
4.5.2. Limited Expertise and Sequencing Capabilities of Small & Mid-sized Laboratories
4.6. The Impact of COVID-19 on the Global NGS Library Preparation Market
4.7. Related/Adjacent Markets
4.7.1. NGS Automation Market
4.8. Technological Trends

5 Global NGS Library Preparation Market, by Product
5.1. Introduction
5.2. Reagents & Consumables
5.2.1. Library Preparation Kits
5.2.1.1. DNA Library Preparation Kits
5.2.1.2. RNA Library Preparation Kits
5.2.2. Other Reagents & Consumables
5.3. Instruments/Workstations

6 Global NGS Library Preparation Market, by Sequencing Type
6.1. Introduction
6.2. Targeted Genome Sequencing
6.3. Whole Genome Sequencing
6.4. Whole Exome Sequencing
6.5. Other Sequencing Types

7 Global NGS Library Preparation Market, by Application
7.1. Introduction
7.2. Disease Diagnostics
7.2.1. Reproductive Health Diagnostics
7.2.2. Cancer Diagnostics
7.2.3. Infectious Disease Diagnostics
7.2.4. Other Disease Diagnostics
7.3. Drug Discovery
7.4. Other Applications

8 Global NGS Library Preparation Market, by End User
8.1. Introduction
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academic Institutes & Research Centers
8.5. Other End Users

9 NGS Library Preparation Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.6. Middle East & Africa

10 Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2022)
10.4.1. Illumina, Inc. (U.S.)
10.4.2. Thermo Fisher Scientific, Inc. (U.S.)
10.4.3. F. Hoffmann-La Roche Ltd (Switzerland)
10.4.4. Agilent Technologies, Inc. (U.S.)

11 Company Profiles
11.1. Illumina, Inc.
11.2. Thermo Fisher Scientific, Inc.
11.3. F. Hoffmann-La Roche Ltd
11.4. PerkinElmer Inc.
11.5. QIAGEN N.V.
11.6. Agilent Technologies, Inc.
11.7. Tecan Group Ltd.
11.8. Pacific Biosciences of California, Inc.
11.9. Danaher Corporation
11.10. New England Biolabs, Inc.
11.11. Merck KGaA
11.12. Diagenode S.A. (A Subsidiary of Hologic, Inc.)

12 Appendix
12.1. Questionnaire
12.2. Available Customization

Companies Mentioned

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Agilent Technologies Inc.
  • Danaher Corporation
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • F. Hoffmann-La Roche AG
  • New England Biolabs Inc.
  • Tecan Group Ltd.
  • Merck KGaADiagenode S.A.